Preferred term | Total | Oral azacitidine (N = 236) | ||||
---|---|---|---|---|---|---|
Maximum CTCAE grade | ||||||
1 | 2 | 3 | 4 | 5 | ||
n (%) | ||||||
Any GI adverse event | 215 (91) | 63 (27) | 118 (50) | 30 (13) | 4 (2) | 0 |
Nausea | 153 (65) | 81 (34) | 66 (28) | 6 (3) | 0 | 0 |
Vomiting | 141 (60) | 81 (34) | 53 (22) | 7 (3) | 0 | 0 |
Diarrhea | 119 (50) | 62 (26) | 45 (19) | 11 (5) | 1 (< 1) | 0 |
Constipation | 91 (39) | 52 (22) | 36 (15) | 3 (1) | 0 | 0 |
Abdominal pain | 31 (13) | 19 (8) | 10 (4) | 2 (1) | 0 | 0 |
Upper abdominal pain | 21 (9) | 14 (6) | 5 (2) | 2 (1) | 0 | 0 |
Flatulence | 13 (6) | 9 (4) | 4 (2) | 0 | 0 | 0 |